Skip to content Skip to footer
Subscribe Now
Insights+: Key Events of ASCO 2019
INSIGHTS+
Insights+: Key Events of ASCO 2019
The American Society of Clinical Oncology (ASCO) is a platform for cancer experts to share views on latest advancement and new approaches in cancer research. In the 55th session of ASCO 2019, 2400+ abstracts were presented. IBM Watson Health was also a part of ASCO 2019 with its advancement in Oncology, Genomics and Patient Monitoring.…
July 6, 20190Comments
Insights+ Key Biosimilars Events of June 2019
INSIGHTS+
Insights+ Key Biosimilars Events of June 2019
Biosimilars are key alternatives for costly Biologics therapies and saving million dollars of patients in multiple diseases. Hence physicians are likely to adopt biosimilars a reference product to biologics which are biologically like biologics. They possess similar therapeutic properties in terms of potency, safety, and efficacy to original biologic products. Our team at PharmaShots have…
July 4, 20190Comments
Insights+ Key Biosimilars Events of May 2019
INSIGHTS+
Insights+ Key Biosimilars Events of May 2019
Biosimilars are going in market with vast emerging needs of people for multiple diseases. The biologics that are too costly to be used in the markets. Hence physicians are developing biosimilars a reference product to biologics which are biologically similar to biologics. Our team at PharmaShots have summarized some of the news regarding biosimilars in…
June 4, 20190Comments
Oncology Companies Top 10 2018
TOP 20
Top 10 Oncology Companies By 2018 Revenue
The Pharma companies focusing on oncology has been emerging in market with greater needs of people suffering from Cancer. The sales of oncology drugs gradually increasing with diseases. The top oncology companies are now developing more advanced- effective- and tolerable drugs to improve treatment outcomes and the patient experience. Roche proved to be on top…
May 31, 20190Comments